Research area
Lung Cancer biologic therapy trials
Every lung cancer study listed here tests a biologic, such as a vaccine, an antibody, or a cell or gene therapy. Whether you are looking for yourself or for someone you care for, Cancer Biologic Trials can help you find out if a study may be a fit.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Lung cancer biologic therapy studies in numbers
- lung cancer biologic therapy studies recruiting in the U.S.
- 121
- states with a study site
- 50
Source: ClinicalTrials.gov. Data processed .
Find lung cancer biologic therapy studies by state
These states have the most studies recruiting right now.
California
46 studies recruiting.
Florida
42 studies recruiting.
New York
42 studies recruiting.
Texas
38 studies recruiting.
Ohio
37 studies recruiting.
Pennsylvania
34 studies recruiting.
Lung cancer biologic therapy studies recruiting now
As of November 18, 2026, 121 lung cancer biologic therapy studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry. This is what they have in common.
What they test
- biologics such as vaccines or antibodies117
- medications74
- procedures37
- other approaches22
- radiation9
A study can test more than one.
Main purpose
- treating a condition112
- other purposes2
- prevention1
- supportive care1
Phase
- Early Phase 11
- Phase 131
- Phase 1/227
- Phase 233
- Phase 2/31
- Phase 322
- No phase1
- Observational5
Studies of devices and behavioral approaches have no phase.
Who runs them
- industry61
- university, hospital or other50
- government10
Who they enroll
- adults (18 to 64)120
- older adults (65 and over)120
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 121 studies.
Recently updated lung cancer biologic therapy studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- ‘Aiea, HI · ‘Ewa Beach, HI · Aberdeen, MD · and 223 more U.S. locations
- Registry record
- NCT06498635 · updated
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Recruiting in
- Abilene, TX · Alameda, CA · Anaheim, CA · and 86 more U.S. locations
- Registry record
- NCT06767514 · updated
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Ames, IA · Anaconda, MT · Anaheim, CA · and 124 more U.S. locations
- Registry record
- NCT07388524 · updated
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Albuquerque, NM · Bethlehem, PA · Burbank, CA · and 13 more U.S. locations
- Registry record
- NCT06422143 · updated
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Aurora, CO · Bethlehem, PA · Boston, MA · and 41 more U.S. locations
- Registry record
- NCT06623422 · updated
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Atlanta, GA · Baltimore, MD · Charlotte, NC · and 28 more U.S. locations
- Registry record
- NCT06287775 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in the United States on ClinicalTrials.gov.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.
Cancer Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
What lung cancer biologic therapy studies look at
Every lung cancer study listed here tests a biologic: a vaccine, an antibody, or a cell or gene therapy, for example. Each one sets out to answer a single question of its own. Because of that, the visits and tasks involved for you, or for the person you are reading for, will not match those of another study.
The thing under test in any study is investigational. Put plainly, its risks and the extent of any benefit are both still open questions for researchers, and the study exists to answer them.
Who may be able to take part
No two lung cancer biologic trials ask for exactly the same things. A study's requirements may cover how old you are, your past health, which medicines you are on today, and how the condition is affecting you. Some studies also enroll people who do not have the condition at all.
Whether you are reading for yourself or for a family member, nobody expects you to figure out eligibility alone. The study team checks it during a screening visit. Read how eligibility and screening work.
What taking part usually involves
A first conversation
Before anything else happens, you talk with a coordinator, who gives a general outline of the lung cancer study and takes whatever questions you or your family have.
Informed consent
Next comes the paperwork. Everything about the study, its known risks included, is handed to you in written form by the study team. Agreeing or not is up to you.
Screening
Screening is how suitability gets decided: you answer questions about your health and have some tests. Being screened is not the same as joining, and not every person screened ends up taking part.
Study visits
Joining means coming in for visits on a set schedule, which lets the team keep track of how you are doing. You stay free to withdraw whenever you choose.
Questions about lung cancer biologic therapy studies
Do I need a diagnosis to join a study about lung cancer?
Each lung cancer biologic therapy trial sets its own rule on this. A confirmed diagnosis is needed for some, while others assess you as part of screening. Whether you are asking for yourself or a family member, the study team will explain which applies.
Would I have to change the care I receive now?
Please leave your current care exactly as it is. Nothing should change on your own initiative. Whether that care can continue depends on the study, since some allow it and some do not. A study doctor goes over the question together with you. Before you decide anything, you are free to bring it to your regular doctor too.
Is there a cost to take part?
In general, participants are not charged for the visits, the tests, or the medication a lung cancer biologic study involves. Our page on costs has more detail.
Ask about lung cancer biologic therapy studies
Tell us a few details about yourself or the person you are helping, and a coordinator will get in touch. Asking about a lung cancer biologic trial commits you to nothing.
Independent information
- Lung Cancer — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)